---
category: news
title: "Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy"
excerpt: "Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene"
publishedDateTime: 2021-01-19T06:05:00Z
originalUrl: "https://www.prnewswire.com/news-releases/neurophth-and-aavnergene-enter-strategic-aav-capsids-partnership-for-next-generation-ophthalmic-gene-therapy-301210596.html"
webUrl: "https://www.prnewswire.com/news-releases/neurophth-and-aavnergene-enter-strategic-aav-capsids-partnership-for-next-generation-ophthalmic-gene-therapy-301210596.html"
type: article
quality: 20
heat: 20
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.prnewswire.com/content/dam/prnewswire/common/prn_facebook_sharing_logo.jpg"
    width: 600
    height: 315
    isCached: true

secured: "xqrfKpJ2ls6UaeQqN3clDY6n0+v87iZt2pACoj0f9srzN6AXjSnuqjRGbykYCOo6GBQVcIanqKnJsJpDyab00T28wfnmQbMhIzYvrgOyelWBbOJ++DtUA4Qk0lrx5skQ2JTMHXljtvo8bkW3EABp5pfdJ9Mr15B87SlcZdL80ZRIyGRocziH0gqrrjWuLYzhrHRJ6bHnbqkh0Y2DqqFNJ7pBR5mz2Rpy09dKDnqDstRJBxRL0GNBYTdjSWJ4U8hHsFakbnrI+aTyY2LwBbEo04glitRscVkaZxTKrMJd3RhKr0zCASqExKY03h41pQE7yJh/eclUvML/kRMqikbx/e1YA7AzjCKdO4xsi/+rHik=;BujQnGMbrKFVB5Kw/4HvZg=="
---

